Develops drugs for HIV and dietary supplements for immune systems.
Dec 2024Revenue $0.00/yrExpenses $95.8K/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will Nika Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $0.00 and expenses $95.8K.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $0.00 | $95.8K | −$95.8K |
| Dec 2023 | $0.00 | $64.8K | −$64.8K |
| Dec 2022 | $0.00 | $3.18M | −$3.18M |
| Dec 2021 | $0.00 | $14.7K | −$14.7K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.